According to Biotest 's latest financial reports the company's current EPS (TTM) is -$0.50. In 2022 the company made an earnings per share (EPS) of -$1.52 an increase over its 2021 EPS that were of -$3.32.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.47 | -69.17% |
2022 | -$1.52 | -54.27% |
2021 | -$3.32 | 99.36% |
2020 | -$1.67 | 471.15% |
2019 | -$0.29 | -103.03% |
2018 | $9.63 | -9663.05% |
2017 | -$0.10 | -95.43% |
2016 | -$2.20 | -47.94% |
2015 | -$4.23 | -468.28% |
2014 | $1.15 | -42.66% |
2013 | $2.00 | -8.51% |
2012 | $2.19 | -31.45% |
2011 | $3.20 | 30.12% |
2010 | $2.46 | 36.09% |
2009 | $1.80 |